The legalisation of medical cannabis marks an exciting time in healthcare. It’s a brand new industry with huge opportunities. Cymra Life Sciences combines pharmaceutical industry expertise and plant based science to deliver the high quality whole plant medical cannabis to the Australian market.
In 2018, Cymra secured licences from the Office of Drug Control for both the cultivation and manufacturing of cannabis oil, one of just a few Australian companies to own the full supply chain including cultivation, production, manufacturing and distribution.
The philosophy of Cymra places innovation and Intellectual Property at the core of our business around genetics and pharmaceutical drug development
Want to keep up to date with the latest Medical Cannabis Information in Australia and from around the world?
We will send you informative information from time to time so you can learn about cannabis and if it can help you.
If you are interested in accessing our AGM content and agenda please click here https://drive.google.com/file/d/1cNoaS71wFnINSJYKFv3frxlE6z9kxy8l/view?usp=sharing
If you are having trouble with access please email Simon or Joel
If you are a healthcare professional or patient and you would like more information about our products or medical trials, please get in touch.
© 2021 Cymra Life Sciences – Vir Pharma Holdings – ABN 54 621 123 760